Antibiotic treatment of acute uncomplicated cystitis based on rapid urine test and local epidemiology:Lessons from a primary care series

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Etienne, Manuel ^a   Lefebvre, Emmanuel ^b   Frebourg, Noëlle ^a   Hamel, Hélène ^a   Pestel Caron, Martine ^a   Caron, François ^a   André, Philippe ^c   Barbot, Alain ^c   Bénard, Nicole ^c   Bouillon, Daniéle ^c   Boulet, Pascal ^c   Bourez, Thomas ^c   Brenet, Laurence ^c   Bunel, Jean Michel ^c   Courtier, Martine ^c   De Golmard, François ^c   Durand, Marc ^c   Fainsilber, Pierre ^c   Hautot, Rodolphe ^c   Hermil, Jean Loup ^c   Julienne, Pascal ^c   Lagaude, Marie Catherine ^c   Larese, Karine ^c   Laval, Laurent ^c   Le, Rrené ^c   Janick, ^c   Lefebvre, ^c   Lefebvre, Laure ^c   Lejeal, Serge ^c   Longueville, Jérome ^c   Mineo, Jean Pierre ^c   Nguyen than, Philippe ^c   Odoux, Xavier ^c   Othman, Marc Henri ^c   Peluchon, Roseline ^c   Salaun, Marc ^c   Taupin, Sébastien ^c   Thueux, Jean Paul ^c   Valla, Françoise ^c   Van Elslande, Jean ^c   more..

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b Groupe de Recherche MERCI (EA 3829)   (France)

^c Primary care department Medical Faculty ^*

Author keywords

Acute uncomplicated cystitis; Antibiotic policy; Primary care; Rapid urine test; Urinary tract infection

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; COTRIMOXAZOLE; ERYTHROMYCIN; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; LEVOFLOXACIN; LINCOMYCIN; NETILMICIN; NITRITE; NITROFURANTOIN; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PIVMECILLINAM; PRISTINAMYCIN; RIFAMPICIN; TICARCILLIN; TIMENTIN; TOBRAMYCIN; VANCOMYCIN;

ACUTE UNCOMPLICATED CYSTITIS; ADULT; AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CASE STUDY; CITROBACTER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SURVEILLANCE; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; KLEBSIELLA; LEUKOCYTE; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MIDDLE AGED; NONHUMAN; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRESCRIPTION; PROTEUS; RAPID TEST; RAPID URINE TEST; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS SAPROPHYTICUS; STREPTOCOCCUS; URINALYSIS; URINE CULTURE; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CYSTITIS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PRIMARY HEALTH CARE; URINALYSIS; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 84897483893     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-137     Document Type: Article

References (36)

1. AFSSAPS (Agence française de sécurité sanitaire des produits de santé) AFSSAPS Practice recommendations for diagnosis and antibiotic therapy of adult community urinary tract infections. Med Mal Infect 2008, 38 Suppl 3:S203-S252. AFSSAPS (Agence française de sécurité sanitaire des produits de santé).
2. Scottish Intercollegiate Guidelines Network Management of suspected bacterial urinary tract infection in adults:a national clinical guideline. 2012, 1-52. Available at:http://www.sign.ac.uk/pdf/sign88.pdf, Scottish Intercollegiate Guidelines Network.
3. Naber KG, Bergman B, Bishop MC, Bjerklund-Johansen TE, Botto H, Lobel B, Jinenez Cruz F, Selvaggi FP, Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU) EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol 2001, 40(5):576-588. 10.1159/000049840, 11752870, Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU).
4. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE. Infectious Diseases Society of America, European Society for Microbiology and Infectious Diseases:International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women:A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011, 20:e103-e120.
5. Lopardo G, Fridman D, Gonzalez Arzac M, Calmaggi A, Smayevsky J, Podesta O, Clara L. Uropathogen resistance:are laboratory-generated data reliable enough?. J Chemother 2007, 19:33-37.
6. Stamm WE, Counts GW, Running KR, Fihn S, Turck M, Holmes KK. Diagnosis of coliform infection in acutely dysuric women. N Engl J Med 1982, 307:463-468. 10.1056/NEJM198208193070802, 7099208.
7. Société Française de Microbiologie Rémic. Référentiel en Microbiologie Médicale Volume 1 2012, PARIS:Société Française de Microbiologie, 4, Société Française de Microbiologie.
8. McIsaac WJ, Moineddin R, Ross S. Validation of a Decision Aid to Assist Physicians in Reducing Unnecessary Antibiotic Drug Use for Acute Cystitis. Arch Intern Med 2007, 167:2201-2206. 10.1001/archinte.167.20.2201, 17998492.
9. Hummers-Pradier E, Ohse AM, Koch M, Heizmann WR, Kochen MM. Management of urinary tract infections in female general practice patients. Fam Pract 2005, 22(1):71-77.
10. McIsaac WJ, Low DE, Biringer A, Pimlott N, Evans M, Glazier R. The impact of empirical management of acute cystitis on unnecessary antibiotic use. Arch Intern Med 2002, 162:600-605. 10.1001/archinte.162.5.600, 11871930.
11. Christiaens TCM, De Meyere M, Verschraegen G, Peersman W, Heytens S, De Maeseneer JM. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Pract 2002, 52:729-734. 1314413, 12236276.
12. Bent S, Nallamothu BK, Simel DL, Fihn SD, Saint S. Does this woman have an acute uncomplicated urinary tract infection?. JAMA:The Journal of the American Medical Association 2002, 287:2701-2710. 10.1001/jama.287.20.2701, 12020306.
13. Giesen LGM, Cousins G, Dimitrov BD, van de Laar FA, Fahey T. Predicting acute uncomplicated urinary tract infection in women:a systematic review of the diagnostic accuracy of symptoms and signs. BMC Fam Pract 2010, 11:78. 10.1186/1471-2296-11-78, 2987910, 20969801.
14. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Urinary tract infection:self-reported incidence and associated costs. Ann Epidemiol 2000, 10:509-515. 10.1016/S1047-2797(00)00072-7, 11118930.
15. Little P, Turner S, Rumsby K, Jones R, Warner G, Moore M, Lowes JA, Smith H, Hawke C, Leydon G, Mullee M. Validating the prediction of lower urinary tract infection in primary care:sensitivity and specificity of urinary dipsticks and clinical scores in women. Br J Gen Pract 2010, 60:495-500. 10.3399/bjgp10X514747, 2894378, 20594439.
16. Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae:an emerging public-health concern. Lancet Infect Dis 2008, 8:159-166. 10.1016/S1473-3099(08)70041-0, 18291338.
17. Hansen DS, Schumacher H, Hansen F, Stegger M, Hertz FB, Schønning K, Justesen US, Frimodt-Møller N. Extended-spectrum β-lactamase (ESBL) in Danish clinical isolates of Escherichia coli and Klebsiella pneumoniae:Prevalence, β-lactamase distribution, phylogroups, and co-resistance. Scand J Infect Dis 2012, 44:174-181. 10.3109/00365548.2011.632642, 22364227.
18. Ben-Ami R, Rodríguez-Baño J, Arslan H, Pitout JDD, Quentin C, Calbo ES, Azap OK, Arpin C, Pascual A, Livermore DM, Garau J, Carmeli Y. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 2009, 49:682-690. 10.1086/604713, 19622043.
19. Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Ruíz M, Peña C, Almela M, Almirante B, Grill F, Colomina J, Giménez M, Oliver A, Horcajada JP, Navarro G, Coloma A, Pascual A. Community-Onset Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli:Risk Factors and Prognosis. Clin Infect Dis 2010, 50:40-48. 10.1086/649537, 19995215.
20. Briongos-Figuero LS, Gómez-Traveso T, Bachiller-Luque P, Domínguez-Gil González M, Gómez-Nieto A, Palacios-Martín T, González-Sagrado M, Dueñas-Laita A, Pérez-Castrillón JL. Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria. Int J Clin Pract 2012, 66:891-896. 10.1111/j.1742-1241.2012.02991.x, 22897466.
21. Aubin C. Does This Woman Have an Acute Uncomplicated Urinary Tract Infection?. Ann Emerg Med 2007, 49:106-108. 10.1016/j.annemergmed.2006.09.022, 17203544.
22. Hooton TM. Clinical practice. Uncomplicated urinary tract infection. N Engl J Med 2012, 366:1028-1037. 10.1056/NEJMcp1104429, 22417256.
23. Gupta K, Hooton TM, Roberts PL, Stamm WE. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med 2007, 167:2207-2212. 10.1001/archinte.167.20.2207, 17998493.
24. Société Française de Microbiologie Recommandations 2011 du Comité de l'antibiogramme de la Société Française de Microbiologie. 2012, Paris, Société Française de Microbiologie, Société Française de Microbiologie.
25. Falagas ME, Vouloumanou EK, Togias AG, Karadima M, Kapaskelis AM, Rafailidis PI, Athanasiou S. Fosfomycin versus other antibiotics for the treatment of cystitis:a meta-analysis of randomized controlled trials. J Antimicrob Chemother 2010, 65:1862-1877. 10.1093/jac/dkq237, 20587612.
26. Pitkäjärvi T, Pyykönen ML, Kannisto K, Piippo T, Viita P. Pivmecillinam treatment in acute cystitis. Three versus seven days study. Arzneimittelforschung 1990, 40:1156-1158.
27. De Backer D, Christiaens T, Heytens S, De Sutter A, Stobberingh EE, Verschraegen G. Evolution of bacterial susceptibility pattern of Escherichia coli in uncomplicated urinary tract infections in a country with high antibiotic consumption:a comparison of two surveys with a 10 year interval. J Antimicrob Chemother 2008, 62:364-368. 10.1093/jac/dkn197, 18499768.
28. Hovelius B, Mårdh PA, Nygaard-Pedersen L, Wathne B. Nalidixic acid and pivmecillinam for treatment of acute lower urinary tract infections. Scand J Prim Health Care 1985, 3:227-232. 10.3109/02813438509013954, 4081404.
29. Schito GC, Naber KG, Botto H, Palou J, Mazzei T, Gualco L, Marchese A. The ARESC study:an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents 2009, 34:407-413. 10.1016/j.ijantimicag.2009.04.012, 19505803.
30. Nicolle LE. Pivmecillinam for the treatment of acute uncomplicated urinary infection. Int J Clin Pract 1999, 53:612-617.
31. Neuzillet Y, Naber KG, Schito G, Gualco L, Botto H. French results of the ARESC study:clinical aspects and epidemiology of antimicrobial resistance in female patients with cystitis. Implications for empiric therapy. Med Mal Infect 2012, 42:66-75. 10.1016/j.medmal.2011.07.005, 22264668.
32. Sabuncu E, David J, Bernède-Bauduin C, Pépin S, Leroy M, Boëlle P-Y, Watier L, Guillemot D. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med 2009, 6:e1000084. 10.1371/journal.pmed.1000084, 2683932, 19492093.
33. Holmberg L, Boman G, Böttiger LE, Eriksson B, Spross R, Wessling A. Adverse reactions to nitrofurantoin. Analysis of 921 reports. Am J Med 1980, 69:733-738. 10.1016/0002-9343(80)90443-X, 7435512.
34. Linhares IS, Raposo T, Rodrigues AN, Almeida A. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections:a ten-year surveillance study (2000-2009). BMC Infect Dis 2013, 13:1-1. 10.1186/1471-2334-13-1, 3782360, 23280237.
35. Fabre R, Mérens A, Lefebvre F, Epifanoff G, Cerutti F, Pupin H, Tardif D, Cavallo JD, Ternois I. Susceptibility to antibiotics of Escherichia coli isolated from community-acquired urinary tract infections. Med Mal Infect 2010, 40:555-559. 10.1016/j.medmal.2010.03.002, 20417046.
36. Vellinga A, Tansey S, Hanahoe B, Bennett K, Murphy AW, Cormican M. Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli:a multilevel model. J Antimicrob Chemother 2012, 67:2523-2530. 10.1093/jac/dks222, 22729920.